15:59 Apr 29

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
888.05
+1.50 (+0.17%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
888.05
+1.50 (+0.17%)
15:59 Apr 29
Quality
image/svg+xml

88/100
High Financial Strength

Valuation
image/svg+xml

45/100
Mid Valuation

Technical

40/100
Technically Neutral

Strength

10

Weakness

0

Opportunity

1

Threats

0

19.46 %

ROE %

13.18 %

ROA %

46.46

EPS

219.70

BVPS

19.74 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
14403.5 15265.2 17237.4 19547.4 22247.4
Operating Expenses +
11016.4 11924.5 13377.5 14163.1 15683.9
Raw Material
4958.3 5907.5 6072 6478.4 6539.1
Increase Decrease in Cost
-156.2 -362.3 238.1 -250.2 -286.7
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2295.1 2434.1 2765.6 3137.6 3546.2
Miscellaneous Expenses
6497.8 7674.4 8200.6 8593.1 5885.3
Operating Profit
3387.1 3340.7 3859.9 5384.3 6563.5
Other Income
45.6 224.7 186.6 284.1 345.3
Depreciation
669.6 713 722.7 764.1 883.2
Interest
158.8 127 129.9 81.2 123.9
Profit before tax and exceptio..
2604.3 2725.4 3193.9 4823.1 5901.7
Exceptional Items
-205.1 112.7 -604.2 -14.2 0
PBT
2399.2 2838.1 2589.7 4808.9 5901.7
Provision for Taxation
193.6 511.7 587.8 977.5 1309.9
Net Profit
2137.6 4572.1 1997.3 3854.4 4595
NET Profit after MI
2133.6 4487.3 1960.3 3859.5 4675
EPS
20.84 43.83 19.3 38.14 45.03
Operating Profit Margin (%)
23.52 21.88 22.39 27.54 29.5
Net Profit Margin (%)
14.81 29.4 11.37 19.74 21.01

ShareHolding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 75.00 75.00 75.00 75.00 75.00
FII 7.30 7.50 7.50 5.60 5.70
MF 6.40 6.30 6.60 7.20 6.70
Public 6.70 6.80 6.80 6.80 6.70
Others 0.00 0.00 0.00 0.00 0.00
Others 4.60 4.40 4.10 5.40 5.90
Shareholder Shares Holding %

Download Our App On: